Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
-
 
WKN: 522723 / Name: Biotest / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Biotest AG VZ Stock

Pros and Cons of Biotest AG VZ in the next few years

Pros
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Biotest AG VZ vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Biotest AG VZ - - - - - - -
MPH Health Care AG 0.800% 0.000% -2.591% -30.370% -16.071% 8.357% -33.569%
Pacira Pharmaceuticals 0.000% -2.030% -15.351% -1.531% 4.324% -65.225% -58.584%
Rockwell Medical Inc. -0.150% 1.711% -18.969% -57.013% -66.096% -45.754% -96.234%

News

EQS-News: Biotest AG: Annual General Meeting approves dividend distribution
EQS-News: Biotest AG: Annual General Meeting approves dividend distribution
EQS-News: Biotest AG: Annual General Meeting approves dividend distribution
EQS-News: Biotests’ positive fibrinogen phase III trial results published in The Lancet’s eClinicalMedicine
EQS-News: Biotests’ positive fibrinogen phase III trial results published in The Lancet’s eClinicalMedicine
EQS-News: Biotests’ positive fibrinogen phase III trial results published in The Lancet’s eClinicalMedicine
EQS-Adhoc: Biotest AG: Delisting of Biotest shares from the Frankfurt Stock Exchange with effect from 6 June 2025
EQS-Adhoc: Biotest AG: Delisting of Biotest shares from the Frankfurt Stock Exchange with effect from 6 June 2025
EQS-Adhoc: Biotest AG: Delisting of Biotest shares from the Frankfurt Stock Exchange with effect from 6 June 2025